Search - tctmd.com

Displaying 141 - 160 of 206

Sort: Relevancy | Date

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

Todd Neale

September 28, 2016

Podcast Heart Sounds

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Daily News

回顾性研究建议亚洲患者日常诊疗中以低剂量 NOAC 代替华法林

Todd Neale

September 26, 2016

News Daily News

Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests

Todd Neale

September 26, 2016

News Daily News

Las Dosis Bajas de Superan a la Warfarina en Pacientes Asiáticos en la Práctica Rutinaria, según un Estudio Retrospectivo

Todd Neale

September 26, 2016

News Daily News

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

Michael O'Riordan

September 22, 2016

News Daily News

英国人的战役：英国医学杂志、柳叶刀继续抨击他汀类药物

Todd Neale

September 19, 2016

News Daily News

Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas

Todd Neale

September 19, 2016

News Daily News

Battle of the Brits: BMJ, Lancet Continue Sniping Over Statins

Todd Neale

September 19, 2016

News Daily News

太多主角：不同指南 CVD 风险评估存在混淆和不一致

Michael O'Riordan

September 16, 2016

News Daily News

Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice

Michael O'Riordan

September 16, 2016

News Daily News

Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa

Michael O'Riordan

September 16, 2016

News Daily News

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Michael O'Riordan

September 15, 2016

News Daily News

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Michael O'Riordan

September 13, 2016

News Daily News

Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns

Todd Neale

September 12, 2016

News Conference News ESC 2016

Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD

Todd Neale

September 09, 2016

News Conference News ESC 2016

When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis

Michael O'Riordan

August 31, 2016

News Conference News ESC 2016

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

Michael O'Riordan

August 30, 2016

Advertisement

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

Top Stories in Cardiology: September 2016

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

回顾性研究建议亚洲患者日常诊疗中以低剂量 NOAC 代替华法林

Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests

Las Dosis Bajas de Superan a la Warfarina en Pacientes Asiáticos en la Práctica Rutinaria, según un Estudio Retrospectivo

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

英国人的战役：英国医学杂志、柳叶刀继续抨击他汀类药物

Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas

Battle of the Brits: BMJ, Lancet Continue Sniping Over Statins

太多主角：不同指南 CVD 风险评估存在混淆和不一致

Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice

Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns

Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD

When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content